M U Shad, C Marsh, S H Preskorn. Show Affiliations »
Abstract
Mesh: See more » AgedAntipsychotic Agents/adverse effectsAntipsychotic Agents/economicsAntipsychotic Agents/therapeutic useBenzodiazepinesDepression/prevention & controlDrug InteractionsFemaleFluoxetine/adverse effectsFluoxetine/economicsFluoxetine/therapeutic useHaloperidol/adverse effectsHaloperidol/economicsHaloperidol/therapeutic useHealth Care CostsHumansOlanzapineParkinson Disease/drug therapyPirenzepine/adverse effectsPirenzepine/analogs & derivativesPirenzepine/economicsPirenzepine/therapeutic useSelegiline/pharmacologySelegiline/therapeutic useTrihexyphenidyl/pharmacologyTrihexyphenidyl/therapeutic use
Substances: See more » Antipsychotic AgentsFluoxetineBenzodiazepinesSelegilinePirenzepineTrihexyphenidylHaloperidolOlanzapine
Year: 2001 PMID: 11199940 DOI: 10.1097/00004714-200102000-00027
Source DB: PubMed Journal: J Clin Psychopharmacol ISSN: 0271-0749 Impact factor: 3.153